�Urodynamix Technologies
Ltd. (TSX-V:URO) announced that its general distribution
partner, Laborie Medical Technologies Inc. has standard CE Mark approval
to begin merchandising the Tetra Bladder Monitor System in Europe. Laborie
was as well granted a medical device license to sell Tetra in accordance of rights
with Health Canada's aesculapian device regulations.
"CE Mark and Health Canada approvals represent pregnant progress in
the commercialisation of Urodynamix's NIRS technologies," said Barry
Allen, President and CEO of Urodynamix. "We look forward to expanding
Tetra's availability in Europe and Canada with Laborie as our world-wide
licensing married person. Following the U.S. launch of Tetra in June 2008, we
now have access to 80 percent of the worldwide urodynamics testing
market place."
Tetra is a noninvasive diagnostic aesculapian device based on Urodynamix's
near infrared spectroscopy (NIRS) technology. An accessory to Laborie's
premium urodynamics systems, Tetra enables non-invasive testing of
bladder activity in patients with lower urinary tract symptoms (LUTS).
About Laborie Medical Technologies
Founded in 1967 by Ray Laborie, Laborie Medical Technologies is the
leading world-wide manufacturer of urodynamics equipment used in the
diagnosis and intervention of self-gratification, BPH, and voiding dysfunction.
As Laborie enters its 41st day of remembrance in business, it has established
itself as 'the' supplier of pelvic floor assessment systems in many key
academic centers. Laborie's AQUARIUS Wireless Urodynamic System is
considered the benchmark diagnostic device for clinical trials and
medical research. Laborie's production line includes urodynamic
diagnostics, biofeedback/stimulation systems, compact ultrasound,
computerized and physical bladder modeling tools, EMR solutions,
consumables, as well as accredited pedagogy.
The network of installed users has afforded Laborie the opportunity to
feed this net with new and exciting technology on a continuous
basis. Recently, Laborie introduced the world's most compact, high
resoluteness USB ultrasound system (NuWav(tm)), and it intends on
providing Tetra(tm) technology in the same manner. Laborie has offices
in Canada, USA, Belgium, China, UK and now Paris, France and San Paulo,
Brazil. It has direct gross revenue and distribution networks in 52 countries
across North America, Europe, Asia and Oceania.
About Urodynamix Technologies Ltd.
Urodynamix Technologies is a Canadian medical device company developing
and commercializing noninvasive medical engineering science based on proprietary
applications of near-infrared spectroscopy (NIRS). The Company is
presently focused on products that aid in the diagnosing and handling of
urinary incontinence, bring down urinary tract symptoms, prostate cancer,
benign prostatic hyperplasia, and traumatic increases in intra-abdominal
insistence that suit abdominal compartment syndrome. Urodynamix's
breakthrough medical technology has the electric potential to beneficially affect
more than 200 million people worldwide.
Certain information contained in this press release may be
forward-looking and is subject to unknown risks, which could cause
actual results to differ materially from those set forth or implied
herein. Although the Company believes that the expectations reflected in
such forward-looking statements are fair, it tin give no assurance
that such expectations will prove correct. The TSX Venture Exchange has
not reviewed and does not accept responsibility for the adequateness or
accuracy of this release.
http://www.urodynamix.com
More info
Subscribe to:
Posts (Atom)